article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Food and Drug Administration (FDA) advisory committees, an analysis of the key patents covering drugs recently approved by the FDA, and an examination of high-risk cardiovascular devices approved by the FDA for use in children and adolescents. Improving the Use of FDA Advisory Committees. N Engl J Med.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

13-year Medicare payment dispute will return to HHS, court rules. Meet new FDA chief Dr. Robert Califf: 5 things to know. Only 14% of Hospitals Met Price Transparency Rule Compliance. A layoff list, expired medicine, neglected patients: Illinois hospital loses Medicare contract. CMS delays star ratings update until July.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. ” These prescriptions for lower pharma costs contrast with what most U.S. The graph is the Nasdaq U.S.

article thumbnail

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

Since the CVS+Aetna announcement last December, the Kaiser Family Foundation ran some numbers on how the merged organization could impact Medicare — a key payor for both health insurance and prescription drugs under Part D. The Academy convened a team with experience and gravitas to inform this report.

article thumbnail

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

Health Populi’s Hot Points: The big wild card in forecasting what prescription drug spending will look like in the U.S. is just how aggressive Dr. Alex Azar at the Department of Health and Human Services, and Dr. Scott Gottlieb at FDA, want to be regarding drug pricing.

article thumbnail

Lower Prescription Drug Prices – A Tri-Partisan Call Across America

Health Populi

A new poll jointly conducted by Politico and the Harvard Chan School of Public Health bolsters my read on the latter issue – prescription drug pricing, which has become a mass popular culture union. This is the tactic that most Americans say could lower prescription drug prices. Why should U.S.

article thumbnail

The State of the Union for Prescription Drug Prices

Health Populi

voters’ priorities, across political party – prescription drug prices. voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Few issues unite U.S.